SEC Form 4 · accession 0001493152-26-029594
Oncotelic Therapeutics, Inc. · OTLC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Amit B. Shah
Officer — CFO
Period of report
Jun 22, 2026
Accepted (ET)
Jun 22, 2026 · 4:30 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000908259
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 22, 2026 | P | 20,000 | $0.05 | A | 378,837 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On June 22, 2026, Amit Shah purchased 20,000 shares of Oncotelic Therapeutics, Inc. in his individual capacity, from the open market at a price of $0.05.